Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening
Open Access
- 15 March 1993
- Vol. 71 (6) , 1982-1988
- https://doi.org/10.1002/1097-0142(19930315)71:6<1982::aid-cncr2820710610>3.0.co;2-g
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Lack of benefit from semi‐annual screening for cancer of the lung: Follow‐up report of a randomized controlled trial on a population of high‐risk males in czechoslovakiaInternational Journal of Cancer, 1990
- Tumour-associated trypsin inhibitor and tumour-associated trypsinScandinavian Journal of Clinical and Laboratory Investigation, 1990
- Screening for lung cancer‐results from a case‐control studyInternational Journal of Cancer, 1987
- Tumor Markers in Patients with Lung CancerChest, 1986
- Screening for Early Lung CancerChest, 1984
- Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.BMJ, 1984
- Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapyCancer, 1982
- Lung Cancer MarkersPublished by Springer Nature ,1982
- A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancerThe American Journal of Surgery, 1979
- Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinomaCancer, 1978